Pure Global
NCT06284200

Presence and Comparison of Sarcopenia in Early Rheumatoid Arthritis and Rheumatoid Arthritis

Kayseri City Hospital·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Sarcopenia
Study type
Observational
Sponsor & location
Primary sponsor
Kayseri City Hospital
Location
Kocasinan, Turkey
Timeline & enrollment
Phase
N/A
Start date
Jun 23, 2023
End date
Jun 23, 2024
Enrollment
48 participants
Primary outcome

Evaluation of Muscle Mass,Evaluation of Muscle Strength,Evaluation of Muscle Performance

Summary

introduction: In this study, the presence of sarcopenia in cases with early rheumatoid
 arthritis and established rheumatoid arthritis will be compared.
 
 Materials and Method: According to the power analysis, 24 patients with early rheumatoid
 arthritis and 24 patients with established rheumatoid arthritis who meet the 2010 American
 College of Rheumatology (ACR) / European Alliance of Associations for Rheumatology (EULAR)
 rheumatoid arthritis (RA) classification criteria will be included in the study.

ICD-10 classifications
Kaposi sarcomaHerniaTaeniasisTaenia saginata taeniasisDiaphragmatic hernia
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06284200
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06284200 through Pure Global AI's free database. This phase not specified trial is sponsored by Kayseri City Hospital and is currently Recruiting. The study focuses on Sarcopenia. Target enrollment is 48 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.